Elena Simioni
Multitarget drug design strategy in Alzheimer’s disease: focus on cholinergic transmission and amyloid-β aggregation
Simioni, Elena; Bartolini, Manuela; Abu, Izuddin Fahmy; Blockley, Alix; Gotti, Cecilia; Bottegoni, Giovanni; Caporaso, Roberta; Bergamini, Christian; Andrisano, Vincenza; Cavalli, Andrea; Mellor, Ian R.; Minarini, Anna
Authors
Manuela Bartolini
Izuddin Fahmy Abu
Alix Blockley
Cecilia Gotti
Giovanni Bottegoni
Roberta Caporaso
Christian Bergamini
Vincenza Andrisano
Andrea Cavalli
IAN MELLOR ian.mellor@nottingham.ac.uk
Assistant Professor
Anna Minarini
Abstract
Background: Alzheimer pathogenesis has been associated with a network of processes working simultaneously and synergistically. Over time, much interest has been focused on cholinergic transmission and its mutual interconnections with other active players of the disease. Besides the cholinesterase mainstay, the multifaceted interplay between nicotinic receptors and amyloid is actually considered to have a central role in neuroprotection. Thus, the multitarget drug-design strategy has emerged as a chance to face the disease network. Results: By exploiting the multitarget approach, the present study provides new molecules able to target the cholinergic pathway, by joining direct nicotinic receptor stimulation to acetylcholinesterase inhibition, and to inhibit A? aggregation. Conclusions: These new compounds emerged as a suitable starting point for a further optimization process.
Citation
Simioni, E., Bartolini, M., Abu, I. F., Blockley, A., Gotti, C., Bottegoni, G., …Minarini, A. (in press). Multitarget drug design strategy in Alzheimer’s disease: focus on cholinergic transmission and amyloid-β aggregation. Future Medicinal Chemistry, 9(10), https://doi.org/10.4155/fmc-2017-0039
Journal Article Type | Article |
---|---|
Acceptance Date | Apr 4, 2017 |
Online Publication Date | Jun 20, 2017 |
Deposit Date | Sep 18, 2017 |
Publicly Available Date | Sep 18, 2017 |
Journal | Future Medicinal Chemistry |
Print ISSN | 1756-8919 |
Electronic ISSN | 1756-8927 |
Publisher | Future Science |
Peer Reviewed | Peer Reviewed |
Volume | 9 |
Issue | 10 |
DOI | https://doi.org/10.4155/fmc-2017-0039 |
Keywords | Alzheimer’s disease, Nicotinic receptors, Acetylcholinesterase inhibitors, Multitarget compounds, Amyloid aggregation. |
Public URL | https://nottingham-repository.worktribe.com/output/867422 |
Publisher URL | https://www.future-science.com/doi/full/10.4155/fmc-2017-0039 |
Files
Rosini_Manuscript_revised.pdf
(825 Kb)
PDF
Rosini_Manuscript_revised.pdf
(883 Kb)
PDF